BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30111533)

  • 1. Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
    Roy S; Bag AK; Dutta S; Polavaram NS; Islam R; Schellenburg S; Banwait J; Guda C; Ran S; Hollingsworth MA; Singh RK; Talmadge JE; Muders MH; Batra SK; Datta K
    Cancer Res; 2018 Oct; 78(19):5600-5617. PubMed ID: 30111533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast Cancer.
    Dhupar R; Jones KE; Powers AA; Eisenberg SH; Ding K; Chen F; Nasarre C; Cen Z; Gong YN; LaRue AC; Yeh ES; Luketich JD; Lee AV; Oesterreich S; Lotze MT; Gemmill RM; Soloff AC
    Front Immunol; 2022; 13():830169. PubMed ID: 35651620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
    Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
    Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.
    Xiong H; Mittman S; Rodriguez R; Moskalenko M; Pacheco-Sanchez P; Yang Y; Nickles D; Cubas R
    Cancer Res; 2019 Apr; 79(7):1493-1506. PubMed ID: 30679180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
    Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
    Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
    Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
    Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
    Varn FS; Schaafsma E; Wang Y; Cheng C
    Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neuropilin-2 in the immune system.
    Schellenburg S; Schulz A; Poitz DM; Muders MH
    Mol Immunol; 2017 Oct; 90():239-244. PubMed ID: 28843905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review.
    Lecoultre M; Dutoit V; Walker PR
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
    Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
    J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model.
    Immormino RM; Jania CM; Tilley SL; Moran TP
    Immun Inflamm Dis; 2022 Mar; 10(3):e575. PubMed ID: 34861108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
    Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar macrophage-derived NRP2 curtails lung injury while boosting host defense in bacterial pneumonia.
    Wang B; Guo W; Qiu C; Sun Y; Zhao C; Wu C; Lai X; Feng X
    J Leukoc Biol; 2022 Sep; 112(3):499-512. PubMed ID: 35435271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
    Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
    J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. slan
    Vermi W; Micheletti A; Finotti G; Tecchio C; Calzetti F; Costa S; Bugatti M; Calza S; Agostinelli C; Pileri S; Balzarini P; Tucci A; Rossi G; Furlani L; Todeschini G; Zamò A; Facchetti F; Lorenzi L; Lonardi S; Cassatella MA
    Cancer Res; 2018 Jul; 78(13):3544-3559. PubMed ID: 29748373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance.
    Islam R; Mishra J; Bodas S; Bhattacharya S; Batra SK; Dutta S; Datta K
    Cancer Metastasis Rev; 2022 Sep; 41(3):771-787. PubMed ID: 35776228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
    Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
    Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.